The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study

Idilman, I.; Celik, A.; Savas, B.; Idilman, R.; Karcaaltincaba, M.

doi:10.1016/j.crad.2021.06.014

The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study

Atıf İçin Kopyala

Idilman I. S., Celik A., Savas B., Idilman R., Karcaaltincaba M.

CLINICAL RADIOLOGY, cilt.76, sa.9, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 76 Sayı: 9
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.crad.2021.06.014
Dergi Adı: CLINICAL RADIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE
Hacettepe Üniversitesi Adresli: Evet

Özet

AIM: To determine the feasibility of magnetic resonance imaging T2 mapping in the quantification of liver steatosis in patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD), and to assess the effect of inflammation and fibrosis on T2 values of the liver.